The high burden associated with respiratory syncytial virus (RSV), has made the development of RSV vaccine(s) a global health high priority. This review summarizes the journey to an RSV vaccine, the different strategies and challenges associated with the development of preventive strategies for RSV, and the diverse products that are undergoing clinical testing.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου